Hirschsprung disease (HSCR) constitutes a congenital absence of ganglion cells within the myenteric and submucosal plexus of ...

The World Gastroenterology Organisation (WGO) has released its 2025 guideline on the diagnosis and management of chronic ...

Meanwhile, a systematic review and meta-analysis in Lancet Gastroenterology & Hepatology examined differences in risks for ...

Dieulafoy lesions are a rare, non-variceal cause of gastrointestinal (GI) bleeding arising from dilated submucosal arteries without any underlying ulcer, which if undiagnosed can cause significant ...

Pouchitis is the most common complication after ileal pouch surgery (also known as J-pouch surgery), a procedure for treating inflammatory bowel disease.

Moderated by Dr. Thomas Chi (UAB), the panel featured Dr. Vernon Pais (Dartmouth), Dr. Karen Stern (Mayo Clinic Arizona), Dr.

Blind loop syndrome (BLS) is a clinical condition characterized by bacterial overgrowth and stasis within intestinal blind loops, which may result from anatomical abnormalities such as diverticula, ...

The bowel screening programme helps to spot bowel cancer before symptoms start, when it’s most treatable. A screening kit will be sent to you in the post if you’re within the age range for the ...

Boomerang Medical announced today that it raised $20 million in a Series B financing to support its implantable neuromodulation system. The women-led bioelectronic medicine company develops its ...

OMass and Genentech collaborate on a preclinical oral small molecule program for IBD, with OMass receiving $20 million upfront and potential milestone payments up to $400 million. OMass leads initial ...

Collaboration leverages OMass’ OdyssionTM platform for the continued development of oral small molecules against a first-in-class target in inflammatory bowel disease OMass to receive $20 million ...